Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona CIBEROBN-Pathophysiology of Obesity and Nutrition, Barcelona Cardiovascular Research Chair, UAB, Barcelona, Spain.
J Thromb Haemost. 2012 Nov;10(11):2373-82. doi: 10.1111/j.1538-7836.2012.04910.x.
Tissue factor (TF) is the most relevant physiological trigger of thrombosis. Additionally TF is a transmembrane receptor with cell signaling functions.
The aim of this study was to investigate TF subcellular localization, function and signaling in human coronary artery smooth muscle cell migration.
Coronary arteries and primary cultures of vascular smooth muscle cells (HVSMC) were obtained from human explanted hearts. Wound repair and Boyden chamber assays were used to measure migration in vitro. TF-pro-coagulant activity (TF-PCA) was measured in extracted cellular membranes. Analysis of TF distribution was performed by confocal microscopy. A nucleofector device was used for TF and protease activated receptor 2 (PAR2) silencing. mRNA levels were analyzed by RT-PCR.
In migrating HVSMC TF translocates to the leading edge of the cells showing an intense patch-like staining in the lamellipodia. In the migrating front TF colocalizes with filamin (FLN) in the polarized lipid rafts. TF-PCA was increased in migrating cells. Silencing of the TF gene inhibits RSK-induced FLN-Ser-2152 phosphorylation, down-regulates CDC42, RhoA, and Rac1 protein expression and significantly inhibits cell migration. Silencing PAR2 also inhibits cell migration; however, silencing both TF and PAR2 induces a significantly higher effect on migration. Smooth muscle cells expressing TF have been identified in non-lipid-rich human coronary artery atherosclerotic plaques.
TF translocates to the cell front in association with cytoskeleton proteins and regulates HVSMC migration by mechanisms dependent and independent of factor (F)VIIa/PAR2. These results extend the functional role of TF to smooth muscle cell trafficking in vessel wall remodeling.
组织因子(TF)是血栓形成最相关的生理触发物。此外,TF 是一种具有细胞信号转导功能的跨膜受体。
本研究旨在探讨 TF 在人冠状动脉平滑肌细胞迁移中的亚细胞定位、功能和信号转导。
从人体移植心脏中获得冠状动脉和血管平滑肌细胞(HVSMC)的原代培养物。体外采用划痕修复和 Boyden 室测定法测定迁移。提取细胞膜中测定 TF 促凝活性(TF-PCA)。通过共聚焦显微镜分析 TF 分布。使用核转染装置进行 TF 和蛋白酶激活受体 2(PAR2)沉默。通过 RT-PCR 分析 mRNA 水平。
在迁移的 HVSMC 中,TF 易位到细胞的前缘,在片状伪足中呈现出强烈的点状染色。在迁移前沿,TF 与肌动蛋白丝(FLN)在极化的脂筏中共定位。迁移细胞中的 TF-PCA 增加。TF 基因沉默抑制 RSK 诱导的 FLN-Ser-2152 磷酸化,下调 CDC42、RhoA 和 Rac1 蛋白表达,并显著抑制细胞迁移。PAR2 沉默也抑制细胞迁移;然而,沉默 TF 和 PAR2 会对迁移产生更高的抑制作用。在非富含脂质的人冠状动脉粥样硬化斑块中已经鉴定出表达 TF 的平滑肌细胞。
TF 与细胞骨架蛋白一起易位到细胞前缘,并通过依赖和不依赖因子(F)VIIa/PAR2 的机制调节 HVSMC 迁移。这些结果将 TF 的功能作用扩展到血管壁重塑中平滑肌细胞的迁移。